Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis, Ultrasound scan, X-ray
Clinical narrative: pain in the chest; rapid heart beat; fever; chills; felt really strange in the evening of 05May2021 and unable to describe how she was feeling; Maternal exposure during pregnancy, third trimester; This is a spontaneous report from a contactable consumer (patient herself) via COVID-19 Vaccine Adverse Event Self-Reporting Solution  portal. This is a maternal report. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in the right arm on 05May2021 at 14:00 at the age of 42 years old (Batch/Lot Number: EW0167, Expiration date: unknown) as dose 2, single for COVID-19 immunization. The vaccine facility type was reported as the military base. Relevant medical history included asthma and known allergies to latex and contrast dye, all from an unknown date and unknown if ongoing. The patient had no COVID-19 prior vaccination. Concomitant medications (in two weeks) included vitamins not otherwise specified (nos) (FLINTSTONES); fluticasone propionate (FLOVENT); acetylsalicylic acid (BABY ASPIRIN); and fluticasone propionate (FLONASE), all taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), administered in the right arm on 14Apr2021 at 03:00 PM (Batch/Lot number: ER8731, Expiration date: unknown) at the age of 42 years old, as dose 1, single for COVID-19 immunization and experienced maternal exposure during pregnancy, second trimester. The patient also experienced maternal exposure during pregnancy, third trimester on 05May2021 at 14:00. The patient's last menstrual date was on 08Oct2020. The patient was 30 weeks pregnant at the time of vaccination and at the onset of the event. The patient was due to deliver on 15Jul2021. The patient delivered the pregnancy on 17Jun2021. The patient felt really strange in the evening of 05May2021 and unable to describe how she was feeling. However, it started to get worse. On 06May2021 at 12:00 AM, the patient experienced pain in the chest, rapid heart beat, fever, and chills. The patient was hospitalized for the events "felt really strange and unable to describe how she was feeling, pain in the chest, rapid heart beat, fever, and chills" on an unspecified date for 4 days. The same events were also considered life threatening (immediate risk of death from the event) and had resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events "felt really strange and unable to describe how she was feeling, pain in the chest, rapid heart beat, fever, and chills," which included nasal levofloxacin (LOVENOX). The patient was tested for COVID-19 post vaccination; COVID-19 test via nasal swab resulted negative on 02Aug2021. The patient had recovered with sequelae from the events "felt really strange and unable to describe how she was feeling, pain in the chest, rapid heart beat, fever, and chills" on an unspecified date in 2021.